跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 33,866 条关于
“Alt-R HDR Enhancer Protein”
全部
33,866
临床试验
18,336
药物
3,590
机构
626
资讯
11,314
去年
IDT Launches HDR Enhancer Protein to Boost CRISPR Gene Editing Efficiency in Therapeutic Applications
2个月前
Global Proteins & Protein Crystals Market Projected to Reach $960 Billion by 2030, Driven by Biopharmaceutical R&D and Structural Biology Advances
去年
ENA Respiratory's Novel Intranasal Antiviral Immune Enhancer Shows Promise in Phase Ib Trial
去年
Boehringer Ingelheim and Tessellate Bio Form €500M Partnership to Target ALT-Positive Cancers
3个月前
R2 Retrotransposons Enable Efficient, DSB-Free Gene Insertion into Plant Genomes
8天前
Alteogen licenses ALT-B4 to Novartis in deal worth up to $3.2 billion
去年
Tenofovir Amibufenamide Shows Significant Efficacy in Chronic Hepatitis B Patients with Normal ALT Levels
2个月前
Monoclonal Antibody ALT-100 Shows Early Promise for ARDS in Proof-of-Concept Trial
8个月前
Alteogen Nears Major Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
2年前
Alteogen Seeks Approval for Aflibercept Biosimilar ALT-L9 in Korea
第 1 页，共 1132 页
上一页
下一页
